PATENT CLAIM ANALYSIS

Application Number: 15780980
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["514", "456000"]

Abstract:
Compositions including the combination of cremastranone analogs and anti-angiogenic agents and the use of the compositions for targeting ocular angiogenesis such as seen in neovascular eye diseases are disclosed.

Claim (Index 21):
The composition as set forth in  claim 1  wherein the synthetic compound comprises the formula

Metadata:
- Claim Count in Document: 10.0
- Percentile: 94.0
- Lexical Diversity: 1.15385
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15889409', '14833041', '15512200', '15602096', '15058938']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.708252943669734
- 35 USC 102 Novelty (BERT): 0.5479510641984171
- Combined Prediction Score: 0.6922227557226024
- Mean Citation Score: 319.820838
- Max Citation Score: 421.37485
- Similarity Product: 254.5439023544908

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 0

Dataset: test